Nanomedicine News

RSS
Cornell and MSKCC to Open New $10 Million Center of Cancer Nanotechnology Excellence

Cornell and MSKCC to Open New $10 Million Center of Cancer Nanotechnology Excellence

Novavax Reports Positive Data from RSV F-Protein Recombinant Nanoparticle Vaccine Phase 1 Clinical Trial

Novavax Reports Positive Data from RSV F-Protein Recombinant Nanoparticle Vaccine Phase 1 Clinical Trial

Mediso Preclinical nanoScan Imaging System Installed at Cold Spring Harbor Laboratory

Mediso Preclinical nanoScan Imaging System Installed at Cold Spring Harbor Laboratory

Nanobiosym Announces Commitment to Deploy Gene-RADAR in Africa to Stop Ebola

Nanobiosym Announces Commitment to Deploy Gene-RADAR in Africa to Stop Ebola

NDSU Researchers Receive NIH Grant to Explore Use of Nanocarriers in Prostate Cancer Therapy

NDSU Researchers Receive NIH Grant to Explore Use of Nanocarriers in Prostate Cancer Therapy

Celator to Present Positive Results of CombiPlex Nanoparticle Technology at AACR-NCI-EORTC International Conference

Celator to Present Positive Results of CombiPlex Nanoparticle Technology at AACR-NCI-EORTC International Conference

Cornell University and MSKCC Open New Center of Cancer Nanotechnology Excellence

Cornell University and MSKCC Open New Center of Cancer Nanotechnology Excellence

Researchers Develop Nanowalker that Moves Across Carpet of DNA Strands

Researchers Develop Nanowalker that Moves Across Carpet of DNA Strands

Carnegie Mellon Professor Named 2015 Brilliant Ten Winner for Innovative Work on Nanoparticle Drug Delivery Systems

Carnegie Mellon Professor Named 2015 Brilliant Ten Winner for Innovative Work on Nanoparticle Drug Delivery Systems

Researchers Develop Allergy Shot that Uses Nanocarriers to Reduce Severe Side Effects

Researchers Develop Allergy Shot that Uses Nanocarriers to Reduce Severe Side Effects

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.